Avid stockholders approve transaction with gho and ampersand

Tustin, calif., jan. 30, 2025 (globe newswire) -- avid bioservices, inc. (nasdaq: cdmo) (“avid” or the “company”), a dedicated biologics contract development and manufacturing organization (“cdmo”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that avid stockholders voted to approve the transaction with gho capital partners llp ("gho") and ampersand capital partners (“ampersand”) at the avid special meeting of stockholders (the “special meeting”) held earlier today.
CDMO Ratings Summary
CDMO Quant Ranking